AGPU AGPU Drug Discovery Services — General And Administrative Expense

Other segment segments

Similar metrics at other companies

FLGTLaboratory Services — General And Administrative Expense

$20.05M-2.8%

FLGTTherapeutic Development — General And Administrative Expense

$357K+36.8%

IRONSignificant Segment Expense Category — General And Administrative Expense

-$9.03M-31.7%

RLMDGeneral and administrative costs

$11.37M+81.5%

CWCOServices — General And Administrative Expense

$1.79M-18.6%

IQVResearch & Development Solutions — Selling, general and administrative expenses

$250M+8.7%

Questions, answered.

What is AGPU's drug discovery services — general and administrative expense?

AGPU (AGPU) reported drug discovery services — general and administrative expense of $1.73M in Q4 2025.

How has AGPU's drug discovery services — general and administrative expense changed year-over-year?

AGPU's drug discovery services — general and administrative expense increased by 241.5% year-over-year, from $505.68K to $1.73M.

What does drug discovery services — general and administrative expense mean?

Covers the overhead costs required to support the Drug Discovery Services segment, including management salaries, office expenses, and legal fees. This metric helps investors evaluate the segment's administrative efficiency and cost control discipline. High expenses relative to revenue may indicate a need for better operational scaling.